Bookmark and Share

This article is in the news archive.

Cambridge Neuroscientists discover a new molecule involved in MS

Scientists have discovered a new molecule that could lead to a drug treatment to repair myelin, the fatty material that coats and insulates nerves. Damage to myelin can cause the symptoms of MS but there are currently no treatments to repair it.

The study, published in Nature Neuroscience, was carried out by scientists at the University of California, San Francisco, and the University of Cambridge, and funded by the MS societies of the US and UK.

Robin Franklin, Professor of Neuroscience at Cambridge and co-author of the study, and pictured above, said:

"There are currently no treatments that repair damage to myelin caused by MS, which is a missing link in the treatment of the condition.

"This discovery means we now have even more credible opportunities to promote myelin repair, which is a really promising step forward.

"Our efforts will now be focused on translating these findings into treatments for people with MS."

Dr Doug Brown, head of biomedical research at the MS Society said: "We are excited to see this work moving towards clinical trials and hope it will lead to a new form of treatment for MS sufferers within 10-15 years."

Posted on 29/06/2011

Further news

Go to the news index page.